Fidia Farmaceutici, S.p.A. Presents Hymovis, A New Generation Hyaluronan, At The American College of Rheumatology Annual Meeting In San Francisco

PARSIPPANY, N.J.--(BUSINESS WIRE)--Fidia Farmaceutici, a world leader in the research, development and manufacturing of hyaluronic acid (HA)-based products, and its wholly owned subsidiary, Fidia Pharma USA Inc., will present Hymovis® (high molecular weight viscoelastic hyaluronan) at the American College of Rheumatology (ACR) Annual Meeting in San Francisco, Nov. 8-11, 2015.

Help employers find you! Check out all the jobs and post your resume.